On ECHEMI
Home > Drugs > Isosorbide mononitrate extended-release tablets

Isosorbide mononitrate extended-release tablets

Function and Efficacy

Isosorbide mononitrate is the main active metabolite of isosorbide dinitrate. It can reduce myocardial oxygen consumption by dilating peripheral blood vessels, especially increasing venous blood volume, reducing reflux, and reducing cardiac preload and postload; it can also improve blood supply to ischemic areas by promoting myocardial blood flow redistribution, and may play an anti-myocardial ischemic role through these two aspects.

Ingredients

The main ingredient of this product is isosorbide mononitrate.

Name Description Content CAS NO. Manufacturer
Isosorbide 5-mononitrateIngredients

It can reduce myocardial oxygen consumption by dilating peripheral blood vessels, especially increasing venous blood volume, reducing reflux, and lowering cardiac anterior and posterior loads; it can also improve blood supply to the ischemic area by promoting redistribution of myocardial blood flow, and may exert its anti-myocardial ischemia effect through these two aspects.

More
16051-77-7 22

Appearance

This product is an off-white tablet or film-coated tablet, which appears white or off-white after removing the coating.

Indication

Long-term treatment of coronary heart disease; prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure.

Usage and Dosage

Oral: Take 1 tablet every morning. For severe cases, take 2 tablets every morning. If headache occurs, the initial dose can be reduced to half a tablet per day. The whole tablet or half tablet should be kept intact before taking, swallowed with half a cup of water, and should not be chewed or crushed.

Adverse Reactions

Nitrate-induced vasodilatory headache may occur in the early stage of medication, but the symptoms usually disappear after taking it for several days. Facial flushing, dizziness, orthostatic hypotension and reflex tachycardia may also occur. Occasionally, blood pressure is significantly reduced, bradycardia, angina pectoris is aggravated and syncope may occur.

Precautions

It is contraindicated for patients with glaucoma, shock, significant hypotension, hypertrophic obstructive heart disease, acute myocardial infarction, and severe cerebral arteriosclerosis.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women. Precautions for the elderly: Not yet clear.

Drug Interactions

Not yet clear.

Storage

Keep away from light and store in sealed container.

Packaging Specification

40 mg

Validity Period

24 months.

Manufacturer

Shanghai New Asiatic Medicine Industry Minhang Co., Ltd.

  • Founded in:

    1989-07-06
  • Address:

    No. 1500, Kunyang Road, Minhang District, Shanghai
  • Tax NO.:

    91310112133354160Q
  • Registered Funds:

    57.5 million yuan
  • Email:

Other Drugs of Shanghai New Asiatic Medicine Industry Minhang Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.